JOHN MARAGANORE
CIK 1180432 · Chief Executive Officer · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$66.26M
Companies
9
Total Filings
120
Lifetime Open-Market Net
-$121.06M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RAPP | Director | — | $38.40 | — | $0 | 2 | 2026-06-10 |
| BEAM | Director | — | $29.03 | — | $0 | 6 | 2026-06-05 |
| COAG | Director | 35,948 | — | — | $0 | 1 | 2026-05-04 |
| KYMR | Director | — | $86.20 | — | $0 | 4 | 2025-06-26 |
| PROK | Director | — | $1.64 | — | $0 | 1 | 2023-07-03 |
| AGIO | Director | 30,028 | $29.46 | $884.6K | -$1.80M | 18 | 2022-06-23 |
| ALNY | Chief Executive Officer | 231,115 | $282.85 | $65.37M | -$114.58M | 77 | 2021-12-23 |
| bluebird bio, Inc. (BLUE) Delisted | Director | 24,711 | $4.97 | $122.8K | -$4.68M | 9 | 2017-09-18 |
| Regulus Therapeutics Inc. (RGLS) Delisted | Director | 6,150,500 | $8.16 | $50.19M | $0 | 1 | 2012-10-11 |
Recent Filings · Page 10 of 12
120 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-12-18 | ALNY | Grant (A) | — | $0 | EDGAR |
| 2013-12-06 | AGIO | Grant (A) | — | $0 | EDGAR |
| 2013-10-15 | ALNY | Exer (M) | +12,665 | $85.9K | EDGAR |
| 2013-09-24 | ALNY | Grant (A) | — | $0 | EDGAR |
| 2013-09-12 | ALNY | Mixed | — | -$3.22M | EDGAR |
| 2013-08-16 | ALNY | Mixed | — | -$2.88M | EDGAR |
| 2013-07-12 | ALNY | Mixed | — | -$2.17M | EDGAR |
| 2013-02-28 | ALNY | Sell (S) | −58,503 | -$1.37M | EDGAR |
| 2012-12-21 | ALNY | Mixed | +18,617 | $8.8K | EDGAR |
| 2012-10-11 | Regulus Therapeutics Inc. (RGLS) Delisted | Conv (C) | +6,150,500 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.